Philips initiated a voluntary recall for some of its sleep apnea machines and ventilators. The American multinational conglomerate company cited concerns for a foam component that may get detached or degrade and become toxic when inhaled by the user.
It was said that if such a thing happens, there is a possibility it could cause health issues including the development of cancer due to toxic and carcinogenic effects. To prevent this and protect the users, Philips issued a recall notification on Monday, June 14.
The affected devices and Philips’ announcement
As per Fox Business, the Philips recall will affect three to four million units of certain machine models that feature Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAC) and the mechanical ventilator machines. It was revealed that the company already issued the first warning over the issue in April.
Philips announced its voluntary recall notification after consulting with regulatory agencies. The company said that with the recalled products, the company will immediately take corrective actions that include the distribution of updated instructions for the repair and replacement of the affected items. As of this time, Philips is continuously monitoring reports of safety issues and so far, it has not received any reports of death due to the product issues.
It was added that due to potential risks of exposure, users may experience headaches, respiratory issues, irritation, inflammation and possible toxic or carcinogenic effects. But fortunately, there is no report of these effects yet related to chemical emissions.
“We deeply regret any concern and inconvenience that patients using the affected devices will experience because of the proactive measures we are announcing today to ensure patient safety,” Philips CEO, Frans van Houten, said in a press release. “In consultation with the relevant regulatory agencies and in close collaboration with our customers and partners, we are working hard towards a resolution. Patient safety is at the heart of everything we do at Philips.”
How Philips will solve the issue
Reuters reported that Philips is now working with the health authorities and regulators for the safety of the consumers. It is looking for a way for the safe replacement of the foam that may potentially become toxic and cause cancer.
It was added that Philips is not conducting tests and it needs to get good results so it can pass the regulatory requirements. The company will also be replacing the products that cannot be repaired or updated.


Tesla Faces 19% Drop in UK Registrations as Competition Intensifies
Microchip Technology Boosts Q3 Outlook on Strong Bookings Momentum
Asian Markets Stabilize as Wall Street Rebounds and Rate Concerns Ease
Australia’s Economic Growth Slows in Q3 Despite Strong Investment Activity
Magnum Audit Flags Governance Issues at Ben & Jerry’s Foundation Ahead of Spin-Off
Asian Markets Mixed as RBI Cuts Rates and BOJ Signals Possible Hike
European Oil & Gas Stocks Face 2026 With Cautious Outlook Amid Valuation Pressure
GM Issues Recall for 2026 Chevrolet Silverado Trucks Over Missing Owner Manuals
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts
USPS Expands Electric Vehicle Fleet as Nationwide Transition Accelerates
Asian Currencies Steady as Rupee Hits Record Low Amid Fed Rate Cut Bets
Tesla Expands Affordable Model 3 Lineup in Europe to Boost EV Demand
Visa to Move European Headquarters to London’s Canary Wharf
Anthropic Reportedly Taps Wilson Sonsini as It Prepares for a Potential 2026 IPO
Citi Sets Bullish 2026 Target for STOXX 600 as Fiscal Support and Monetary Easing Boost Outlook
OpenAI Moves to Acquire Neptune as It Expands AI Training Capabilities 



